V.P.M. van Empel

Vranken, N. P. A., Li, X., Bouman, H., Mourmans, S. G. J., Achten, A., Aizpurua, A. B., Brunner-La Rocca, H.-P., Knackstedt, C., van Empel, V. P. M., & Weerts, J. (2025). Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fraction. Cardiovascular Diabetology, 24(1), Article 156. https://doi.org/10.1186/s12933-025-02708-6

van Koll, J., Engels, M. D. E. A., Rijks, J. H. J., Salari, M., Luijten, J., Lumens, J., van Empel, V. P. M., Westra, S. W., van Stipdonk, A. M. W., Lankveld, T. A. R., Chaldoupi, S. M., Joza, J., Beukema, R. J., Luermans, J. G. L. M., Linz, D. K., & Vernooy, K. (2025). Long-term outcomes of pace-and-ablate strategy in patients with atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, Article 100786. Advance online publication. https://doi.org/10.1007/s10840-025-02038-3

Suthahar, N., Mourmans, S. G. J., Achten, A., Aboumsallem, J. P., Meijers, W. C., Bomer, N., Kardys, I., Gansevoort, R. T., Bakker, S. J. L., Weerts, J., Eringa, E. C., Damman, K., van Empel, V., & de Boer, R. A. (2025). Peroxiredoxin-4, a marker of systemic oxidative stress, is associated with incident heart failure. European journal of heart failure, Article 3653. Advance online publication. https://doi.org/10.1002/ejhf.3653

Achten, A., Weerts, J., van Koll, J., Ghossein, M., Mourmans, S. G. J., Aizpurua, A. B., van Stipdonk, A. M. W., Vernooy, K., Prinzen, F. W., Rocca, H.-P. B.-L., Knackstedt, C., & van Empel, V. P. M. (2025). Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction. IJC Heart and Vasculature, 57, Article 101622. https://doi.org/10.1016/j.ijcha.2025.101622

Achten, A., Muller, S. A., Zwetsloot, P.-P., Michels, M., van der Meer, P., Nienhuis, H. L. A., van der Meer, M. G., van Empel, V. P. M., Oerlemans, M. I. F. J., & Knackstedt, C. (2025). Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification? Expert review of cardiovascular therapy, 23(1-2), 1-4. https://doi.org/10.1080/14779072.2025.2463333

Stroeks, S. L. V. M., Muller, S., Beelen, N. J., Venner, M. F. G. H. M., Baas, A. F., van Empel, V. P. M., Krapels, I. P. C., Hazebroek, M. R., Te Riele, A. S. J. M., & Verdonschot, J. A. J. (2025). Family Screening in Patients With Dilated and Arrhythmogenic Cardiomyopathy: The Road Toward Gene-Specific Recommendations. Circulation: Genomic and Precision Medicine, 18(1), Article e004778. https://doi.org/10.1161/CIRCGEN.124.004778

Heuts, S., Kawczynski, M. J., Leus, A., Godinas, L., Belge, C., van Empel, V., Meyns, B., Maessen, J. G., Delcroix, M., & Verbelen, T. (2025). The volume-outcome relationship for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. European Respiratory Journal, 65(2). https://doi.org/10.1183/13993003.01865-2024

Mourmans, S. G. J., Weerts, J., Baumert, M., Aizpurua, A. B., Achten, A., Knackstedt, C., Linz, D., & van Empel, V. P. M. (2025). Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fraction. Esc heart failure, 12(1), 622-630. https://doi.org/10.1002/ehf2.15116

Gan, S., Azzo, J. D., Zhao, L., Pourmussa, B., Dib, M. J., Salman, O., Erten, O., Ebert, C., Richards, A. M., Javaheri, A., Mann, D. L., Rietzschel, E., Zamani, P., van Empel, V., Cappola, T. P., & Chirinos, J. A. (2025). Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic Associations. Circulation-Heart Failure, 18(2), Article e011728. https://doi.org/10.1161/CIRCHEARTFAILURE.124.011728

van Loon, T., Rijks, J., van Koll, J., Wolffs, J., Cornelussen, R., van Osta, N., Luermans, J., Prinzen, F., Linz, D., van Empel, V., Delhaas, T., Vernooy, K., & Lumens, J. (2024). Accelerated atrial pacing reduces left-heart filling pressure: a combined clinical-computational study. European Heart Journal, 45(46), 4953-4964. https://doi.org/10.1093/eurheartj/ehae718